BioOrbit
Silver Sponsor
BioOrbit is a biotech company pioneer the first scalable platform for crystallizing biologic drugs in microgravity. Founded in 2023, BioOrbit tackles a variety of pharmaceutical bottlenecks including achieveing high-concentration, low viscosity formualtions suitable for subcutaneous injectoin. Microgavirt offers superior crystal quality, as shown by Merck's pembrolizumab (Keytruda) study on the ISS. Commercial scalability has remained elusive until now! BioOrbit's proprietary platform and fully autonomous hardware enable scaled production on orbit and terrestrially using a unique flow chemistry process. With BioOrbit's first on-orbit demonstration to the ISS complete and the next missions booking out quickly, BioOrbit is moving fast to unlock the use of microgravity to make the next blockbuster drug.
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events